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Ehrlichia chaffeensis is a small, gram negative, obligately intracellular bacterium that
preferentially infects mononuclear phagocytes. It is the etiologic agent of human
monocytotropic ehrlichiosis (HME), an emerging life-threatening tick-borne zoonosis.
Mechanisms by which E. chaffeensis establishes intracellular infection, and avoids
host defenses are not well understood, but involve functionally relevant host-pathogen
interactions associated with tandem and ankyrin repeat effector proteins. In this review,
we discuss the recent advances in our understanding of the molecular and cellular
mechanisms that underlie Ehrlichia host cellular reprogramming strategies that enable
intracellular survival.
Keywords: Ehrlichia chaffeensis, tandem repeat proteins (TRPs), cell signaling, post translational modification
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INTRODUCTION
Ehrlichia species are gram negative, obligately intracellular alpha-proteobacteria which belong to
the family Anaplasmataceae in the order Rickettsiales (Anderson et al., 1991; Dumler et al., 2001).
Anaplasmataceae includes the genera Anaplasma, Neorickettsia, and Wolbachia. The Ehrlichia
genus contains six named species: E. chaffeensis, E. ewingii, E. canis, E. muris, E. ruminantium,
and E. ovis, which infect a variety of vertebrate hosts (Buller et al., 1999; Olano et al., 2004; Allsopp
et al., 2005; Perez et al., 2006). Two recently described novel Ehrlichia spp. have been identified,
Ixodes ovataus Ehrlichia (IOE) and E. muris-like agent (EMLA) (Sotomayor et al., 2001; Pritt et al.,
2011; Allen et al., 2014). E. chaffeensis, E. ewingii, and EMLA are considered human zoonotic
pathogens, but E. canis infections in humans have been reported in South America. E. chaffeensis,
E. canis, and E. ewingii naturally infect canids causing clinical manifestations ranging from poly
arthritis to death (Breitschwerdt et al., 1998; Goldman et al., 1998; Dumler et al., 2001). Almost a
century ago, E. ruminantium was isolated from cattle as the etiologic agent of heartwater (Cowdry,
1925). Shortly thereafter, E. canis was identified in the monocytes of tick-infected Algerian dogs
(Donatien and Lestoquard, 1935). Over fifty years later, Ehrlichia infections in humans were first
reported, and E. chaffeensis was subsequently identified in 1992 as an emerging zoonotic pathogen
and the etiologic agent of humanmonocytotropic ehrlichiosis (HME) (Anderson et al., 1992). Most
recently, infections with E. ewingii and EMLA have emerged in humans (Buller et al., 1999; Pritt
et al., 2011; Allen et al., 2014).
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HME is a group I NIAID, emerging, tick-borne zoonosis that
manifests as sepsis or toxic shock syndrome. Patients exhibit flu-
like symptoms that include fever, myalgia, malaise, and headache.
Hematological abnormalities include leucopenia, anemia,
thrombocytopenia, and elevated hepatic aminotransferases
(Ismail et al., 2010). Although, more than 6000 cases have
been reported to the Centers for Disease Control as of 2010,
this number likely underestimates the actual number of cases
by 100-fold based on estimates from prospective studies
(Olano et al., 2003). HME is often underdiagnosed due to its
non-specific symptoms, but is a serious disease that results
in patient hospitalization in 43–62% of cases (Fishbein et al.,
1994). Progression of the disease can result in multisystem
failure, with adult respiratory distress syndrome (ARDS),
meningitis, hepatic, and renal failure being common in many
fatal cases (3%) (Paparone et al., 1995; Patel and Byrd, 1999).
E. chaffeensis, which is transmitted through tick bite, is able to
replicate in mammalian hosts and the tick vector (Ismail et al.,
2010). The geographical distribution of E. chaffeensis infections
coincides with the tick vector (Amblyomma americanum)
and the white-tailed deer (Odocoileus virginianus), which
serves as the primary reservoir in nature (Paddock et al.,
1997).
Despite its small genome and limited number of effector
proteins, Ehrlichia efficiently establishes an intracellular infection
and avoids immune defenses in vertebrate and invertebrate
hosts through complex molecular and cellular reprogramming
strategies. Thus, E. chaffeensis is an excellent model organism
to study host-pathogen interactions and to understand the
molecular pathobiology of obligately intracellular microbes. This
review will highlight the most recent advances in our knowledge
of Ehrlichia molecular and cellular interactions, including the
role newly described tandem repeat protein (TRPs) effectors play
in exploiting host cell-signaling pathways, chromatin epigenetics,
post-translational pathways, in order to subvert innate immune
defenses.
PHYSICAL CHARACTERISTICS AND THE
GENOME
Individual ehrlichiae are coccoid to pleomorphic and vary
in size from small (0.4 µm) to large (between 1 and ≤2
µm) (Popov et al., 1995). E. chaffeensis replicates in an
intracellular, membrane-bound vacuole derived from host cell
membrane, forming microcolonies called morula because they
resembling mulberries. Morula is derived from the latin word
“morum” for mulberry. Each vacuole contains one to more
than 400 ehrlichiae (Barnewall et al., 1997). E. chaffeensis
exhibits tropism for mononuclear phagocytes, and has a biphasic
developmental cycle which involves twomorphologically distinct
forms, the smaller (0.4–0.6 µm), infectious dense cored cell
(DC), and a larger replicating reticulate cell (RC, 0.7-0.9
µm). Ehrlichiae have a gram negative envelope which include
a cytoplasmic membrane and outer membrane separated by
periplasmic space; however, their cell wall lacks peptidoglycan
(PG) (Mavromatis et al., 2006). DCs are usually coccoid in
shape and characterized by an electron dense nucleoid that
occupies most of the cytoplasm while RCs are pleomorphic
in shape and have uniformly dispersed nucleoid filaments and
ribosomes distributed throughout the cytoplasm (Zhang et al.,
2007).
E. chaffeensis has one of the smallest bacterial genome (∼1.3
Mb), encoding up to 1200 proteins, and about half of these genes
have predicted or known functions. The genome sequence of
Ehrlichia species has revealed lowGC content (∼30%), numerous
long tandem repeat sequences (TRs) and one of the smallest
genome to coding ratios, which is attributed to long non-
coding regions (Dunning Hotopp et al., 2006; Frutos et al.,
2006). Presence of long non coding regions and low GC content
are thought to represent degraded genes in the final stage of
elimination, and increased GC to AT mutations found in related
Rickettsiales members (Andersson and Andersson, 1999a,b).
TRs are actively created and deleted through an unknown
mechanism that appears to be compatible with DNA slippage.
Generation of TRs in Ehrlichia serves as a mechanism for
adaptation to the hosts, not to generate diversity. Though TRs
share similar characteristics, there is no phylogenetic relationship
between the TRs from different species of Ehrlichia, suggesting
TRs evolved after diversification of each species (Frutos et al.,
2006).
The genome sequence of Ehrlichia has revealed a number
of genes potentially involved in host-pathogen interactions
including genes coding for tandem and ankyrin-repeat
containing proteins, outer membrane proteins, actin
polymerization proteins, and a group of poly(G-C) tract
containing proteins, which may be involved in phase variation.
Notably, genes encoding proteins associated with biosynthesis
of peptidoglycan (PG) and lipopolysaccharide (LPS) are absent
from the genome. Since, PG and LPS bind to nucleotide-binding
oligomerization domain (Nod)-like receptor proteins and
toll-like receptor proteins (TLR4) to activate leukocytes, the
absence of LPS and PG presumably helps Ehrlichia to evade the
innate immune response elicited by these pathogen-associated
molecular patterns (PAMPs). E. chaffeensis contains two types of
TRs, small (12 bp) and large (100–300 bp) period repeats. These
TRs may play role in regulation of gene expression and phase
variation (Frutos et al., 2007).
Multiple secretion systems have been described in gram
negative bacteria for the delivery of effector proteins. In the
ehrlichial genome, type I and IV secretion systems have been
identified (Collins et al., 2005; Dunning Hotopp et al., 2006;
Mavromatis et al., 2006). E. chaffeensis expresses three two-
component systems (TCS), including histidine sensor kinases:
CcKA, NtrY, and PleC and three response regulators, CtrA, NtrX,
and PleD that contain conserved receiver domains with aspartate
phosphorylation sites. These TCS are expressed sequentially
during the life cycle of Ehrlichia, enabling detection and response
to environmental signals by regulating gene expression (Cheng
et al., 2006; Kumagai et al., 2006). Ehrlichia has decreased coding
capacity for genes involved in transport and regulatory functions.
ORFs encoding σ70 (rpoD) and σ32 (rpoH) are present but σ24
(rpoE) and σ54 (rpoN) are absent from the genome (Dunning
Hotopp et al., 2006).
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INTRACELLULAR DEVELOPMENTAL
BIOLOGY
E. chaffeensis preferentially infects monocytes-macrophages and
its intracellular life cycle is confined to membrane bound
vacuoles. After entry through receptor-mediated endocytosis
(1 h), the DC transition into an intermediate form (IM)-1,
then into a replicating RC. RCs divide by binary fission for
48 h, and then transform into the second intermediate form
(IM)-2, ending the cycle as fully mature DCs by 72 h post-
infection (Zhang et al., 2007). DC ehrlichiae attach and enter
the host cells by interacting with the surface protein DNaseX,
and possibly other glycosylphosphatidylinositol (GPI)-anchored
proteins associated with caveolae (Lin and Rikihisa, 2003b;
Mohan Kumar et al., 2015). The ehrlichial proteins that serve
as adhesins include TRP120 which is preferentially expressed
by DC ehrlichiae, and the outer membrane invasin, entry-
triggering protein or EtpE (ECH1038) (Popov et al., 2000; Mohan
Kumar et al., 2013; Luo et al., 2015). The C-terminus of EtpE
directly binds to mammalian protein DNaseX and facilitates
Ehrlichia entry by interacting with CD147 and hnRNP-K
and activating N-Wiskott-Aldrich syndrome protein (N-WASP)
(Mohan Kumar et al., 2015). Recently, it has been determined
that ehrlichial TRPs interact with an unknown receptors on
the host cell surface activating canonical and noncanonical
Wnt signaling pathways of the host, thereby stimulating
phagocytosis and host cell entry (Luo et al., 2015). Others have
demonstrated that a bacterial second messenger cyclic-di-GMP,
and a serine protease HtrA expressed on E. chaffeensis surface
regulates the stability of TRP120 and ehrlichial internalization
(Kumagai et al., 2010). The phagosomes by which E. chaffeensis
enters the host cells have characteristic features that include
caveolin 1, GM1 ganglioside and phospholipase Cγ2 (Barnewall
et al., 1997). Induction of receptor-mediated phagocytosis also
triggers signaling events including transglutamination, tyrosine
phosphorylation and activation of phospholipase Cγ2 (PLC-
γ2), inositol-(1,4,5)-trisphosphate (IP3) production, and release
of intracellular calcium (Lin et al., 2002; Lin and Rikihisa,
2003b). Recently, induction of these signaling events have been
shown to be directly associated with TRP effectors and activation
of canonical and noncanonical Wnt pathways (Luo et al.,
2015).
The ehrlichial cytoplasmic vacuole has features of early
endosomes, such as the presence of Rab5, transferrin, transferrin
receptor (TfR, CD71), early endosomal antigen 1 (EEA1), and
vacuolar H+-ATPase. Some ehrlichial inclusions also contain
major histocompatibility complex (MHC) class I and II, and
vesicle associated membrane protein 2 (VAMP2) (Barnewall
et al., 1997; Mott et al., 1999). Recently proteomic analysis
detected late endosomal markers such as Rab7 along with Rab5,
and TfR (Cheng et al., 2014). The ehrlichial vacuoles do not
fuse with lysosomes, but the mechanisms behind inhibition of
lysosomal fusion are still not clear and will require further
investigation. Ehrlichia can be transported to neighboring cells
through filopodia during initial stages of infection, or infectious
DCs can be released by cell lysis to start a new infection cycle
(Thomas et al., 2010; Figure 1).
SECRETION SYSTEMS AND EFFECTORS
Gram-negative bacteria secrete a variety of effectors and toxins
through various secretion systems (1-6). E. chaffeensis has a type
IV secretion system (T4SS) and type I secretion system (T1SS),
but lacks a T3SS.
Type I Secretion System
The T1SS is widespread among gram-negative bacteria and
is commonly used for the secretion of factors involved in
nutrient acquisition and virulence. It is an ATP-binding cassette
(ABC) transporter system consisting of an ATP-binding cassette
protein (ABC, ECH0383), a membrane fusion protein of the
HlyD family (MFP, ECH0970), and a TolC outer membrane
protein (ECH1020). Together, these proteins create a channel
which allows for one-step secretion of specific effectors from
the bacterial cytoplasm to the extracellular environment. This
secretion is dependent on recognition of a noncleaved signal
present in the C-terminal 50 amino acids (AA). Although a
conserved sequence has not been identified, T1SS substrates
are typically repeat containing proteins with enrichment of
[LDAVTSIF] AA and a paucity of [KHPMWC] AA in the 50
AA C-terminal region of the protein (Delepelaire, 2004). Using
a heterologous type 1 secretion apparatus of Escherichia coli
several E. chaffeensis T1SS substrates have been experimentally
identified, including the 200 kDa ankyrin repeat protein
(Ank200) as well as several tandem repeat proteins (TRPs) that
have features similar to other type 1 secretion system substrates
such as the repeats in toxin (RTX) family (Wakeel et al., 2011).
Although studies to confirm secretion of TRPs by E. chaffeensis
T1SS have not been performed, secreted TRPs have been detected
in infected cells and cell culture supernatant, suggesting that are
indeed T1SS substrates.
Type IV Secretion System
The T4SS is a nearly ubiquitous transport system found in
a variety of both gram-positive and gram-negative bacteria.
The archetypal gram-negative T4SS occurs in Agrobacteria
tumefaciens and consists of 12 proteins (VirB1-11 and VirD4)
organized into two loci that form a translocating pore complex
and ATPase motor for energy dependent export of DNA
and proteins (Christie et al., 2014). E. chaffeensis contains
genes coding for VirB and VirD proteins. Interestingly, E.
chaffeensis contains multiple duplications including four non-
identical versions of VirB4 (ATPase) and VirB6 (inner membrane
channel component) separated into five loci. Additionally, all
VirB6 homologs were 3–10-fold larger than the prototypical
A. tumefaciens VirB6. All components are co-expressed and
interact during infection, suggesting that E. chaffeensis may
possess a structurally novel inner membrane translocon (Cheng
et al., 2008; Bao et al., 2009; Rikihisa et al., 2009). The E.
chaffeensis T4SS is upregulated during the exponential growth
phase in the monocyte and is also expressed in tick cells,
supporting the idea that this system may play an important
role in E. chaffeensis growth and virulence. Although several
hypothetical T4SS substrates have been identified in E. chaffeensis
including ECH0261, ECH0767, ECH0389, ECH0653, ECH0684,
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 May 2016 | Volume 6 | Article 58
Lina et al. Ehrlichia chaffeensis Phagocyte Reprogramming Strategy
FIGURE 1 | Attachment and intracellular developmental cycle of E. chaffeensis in a mammalian host cell. Infectious dense cored (DC) ehrlichiae that have
well characterized surface proteins including TRP120, TRP47, and EtpE interact with host cell receptors such as the GPI anchored protein DNaseX and other
unknown receptors, triggering receptor mediated phagocytosis. Once inside the host cell, DC ehrlichiae replicates in a membrane bound cytoplasmic vacuole and
recruits both early and late endosomal proteins including Rab5, Rab7, and VAMP2 to the vacuole. The T1SS effector proteins TRP120, TRP32, TRP47, TRP75, and
Ank200 are secreted into the intramorular space and translocate to host cytosol. TRP120 translocates to nucleus. DC ehrlichiae differentiate into replicating reticulate
cells (RC) starting 1 h post infection and divide by binary fission every 8 h for next 48 h to form microcolonies known as morulae. The RC form secrets the T4SS
effector ECH0825 and T1SS effectors TRP75 and TRP32. By 72 h post infection RC forms have transitioned back into infectious DC ehrlichiae. The ehrlichiae are
released by exocytosis or cell lysis.
ECH0877, and ECH0825, only one T4SS substrate (ECH0825)
has been experimentally confirmed. ECH0825 interacts with
VirD4 and is secreted during infection, where it localizes to the
host cell mitochondria and can inhibit host cell apoptosis (Liu
et al., 2012).
Characteristics of E. chaffeensis TRP and
Anks
Many TRPs have been molecularly characterized, initially as
antigens that elicit strong protective antibody responses during
infection directed at continuous species-specific epitopes located
in the TR region (Doyle et al., 2006; Luo et al., 2008, 2009;
Kuriakose et al., 2012). The TR domains in TRP32, TRP47,
and TRP120 are serine-rich and acidic while the TRP75 TR
domain is lysine-rich and basic (Luo et al., 2008, 2009, 2010,
2011; McBride et al., 2011). Despite these similarities, the TRs
found in each protein possess distinct AA sequences that vary
both in length, and number. Additionally, the number of repeats
differs between strains, with the greatest variability observed in
TRP32, which has between 3 (Sapulpa isolate) and 6 (Wakulla
isolate) repeats (Buller et al., 1999). The TRPs range from 198
AAs (TRP32) to 583 AAs (TRP75) in length, but all migrate at
a higher molecular mass than predicted from their sequences
due to their acidic properties (Luo et al., 2009; McBride et al.,
2011). TRP32, TRP75, and TRP120 possess relatively large
C-terminal domains, while TRP47 has a small C-terminus (26
AAs). Despite these differences T1S signals were identified in
the C-terminal domains of all of the TRPs (Wakeel et al., 2011).
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TRP32 and TRP75 are constitutively expressed by both DCs
and RCs, while TRP47 and TRP120 are expressed by DCs only
(Popov et al., 2000; Doyle et al., 2006; Luo et al., 2008; McBride
et al., 2011). All TRPs are transcriptionally active in tick cells,
but only TRP120 was detected at the protein level (Kuriakose
et al., 2011). TRPs are modified by multiple host-mediated post-
translational modification pathways, including phosphorylation
and ubiquitination/SUMOylation and localize to various
subcellular locations, including the nucleus (Figure 2A) (Huang
et al., 2008; Wakeel et al., 2010; McBride et al., 2011; Zhu
et al., 2011; Dunphy et al., 2014). The most extensively studied
ankyrin-repeat protein in E. chaffeensis is Ank200, a major
immunoreactive protein and an effector protein that has a
central region containing multiple ankyrin repeats flanked
by acidic N- and C-terminal regions containing major linear
antibody epitopes (Luo et al., 2010). Ank200 is also secreted
by T1SS and translocates to the host nucleus (Zhu et al., 2009;
Wakeel et al., 2011).
MODULATION OF HOST GENE
EXPRESSION
During E. chaffeensis infection, the host transcriptome exhibits
differential expression of 5–10% of host genes (McBride and
Walker, 2011). Host gene expression appears to be modulated in
part by three primary pathogen directed modi operandi: direct
regulation of host gene expression by ehrlichial nucleomodulins,
modulation of host epigenetic marks, and activation of host
cell signaling pathways that act as nexuses in cell decision-
making processes. Direct transcriptional regulation represents an
efficient means of targeting these cell-fate nexuses. Transcription
factors can regulate the expression of hundreds to thousands
of gene targets while epigenetic regulators can have an even
broader impact on cell fate. The first Ehrlichia nucleomodulin
described was Ank200, which binds to repetitive AT-rich regions
called Alu elements within the promoters and intergenic regions
of genes involved in transcriptional regulation, ATPase activity,
and apoptosis regulation (Zhu et al., 2009). Ank200 targets
are differentially regulated during infection with the majority
being downregulated, but some being highly upregulated. This
is similar to Anaplasma phagocytophilum (A. phagocytophilum)
AnkA, which also binds AT-rich regions within the promoters
of target genes and is able to significantly decrease expression
of its target genes. AnkA gene repression occurs concurrently
with a decrease in acetylation of proximal histones, which
suggests an epigenetic mechanism is involved (Garcia-Garcia
et al., 2009). E. chaffeensisAnk200might also function by binding
specific genes and recruiting host epigenetic regulators to repress
expression of target genes.
Interactions between multiple ehrlichial nucleomodulins may
be necessary for regulating gene expression, as well as temporal
regulation of gene expression by individual TRPs. TRP120 binds
DNA via a tandem repeat DNA binding domain, which is
similar to that described in the transcription activator-like (TAL)
effectors of Xanthomonas and Ralstonia sp. TRP120 binds a
GC-rich motif and targets genes involved with transcriptional
regulation, signal transduction, and apoptosis (Figure 2B).
TRP120 target genes were significantly upregulated during
infection and this phenotype was duplicated when TRP120
protein was transfected into cells (Zhu et al., 2011).
TRP-HOST PROTEIN INTERACTIONS
Recently numerous novel Ehrlichia-host protein interactions
have been identified using a yeast two-hybrid (Y2H) approach,
which has helped define the complex mechanisms by which
E. chaffeensis modulates host cell processes (Wakeel et al., 2009;
Luo et al., 2011; Luo and McBride, 2012). Multiple studies have
determined that TRPs interact with a diverse network of host
proteins involved in many host cellular processes including
cell signaling, transcriptional and translational regulation,
post-translational modification, intracellular trafficking,
cytoskeletal organization, and apoptosis. Co-tranfection, co-
immunoprecipitation and co-localization assays confirmed the
interactions of each TRP with select host proteins during ectopic
expression or during Ehrlichia infection. RNA interference assays
have also confirmed the importance of these host proteins on
ehrlichial survival.
Y2H results have also identified numerous putative common
interacting host proteins of TRPs, including EF1A1, IGHA1,
IGLL5 (interacting with both TRP32 and TRP120), PCGF5,
IgKC, RP4, RPL11, CA1, CLC, and UBB (with TRP47 and
TRP120), indicating the importance of overlapping targets
and the crosstalk/convergence of defined cellular networks by
Ehrlichia through its effectors (Wakeel et al., 2009; Luo et al.,
2011; Luo andMcBride, 2012). Notably, elongation factor 1 alpha
(EF1A) is the second most abundant protein in eukaryotes after
actin and is also one of the most important multifunctional
eukaryotic proteins. In addition to its recognized primary role in
translation, EF1A functions also include cytoskeletal remodeling,
enzyme regulation, and apoptosis, (Condeelis, 1995; Ejiri, 2002).
Polycomb group ring finger protein 5 (PCGF5) is a component
of the polycomb repressive complex (PRC) which mediates
epigenetic regulation (Junco et al., 2013). RPL11 is a subunit
of 60 s ribosomal protein and is also involved in ribosomal
entry and p53 mediated apoptosis (Donati and Thomas, 2012).
The TRP interactions with a wide variety of regions of human
immunoglobulins, suggest the association of TRPs with the host
immune system or apoptosis (Yang et al., 2009).
TRP-interacting proteins also include host transcription
factors. TRP32 interacts with DAZ-associated protein 2
(DAZAP2), a transcription factor associated with the canonical
Wnt pathway, hematopoietically expressed homeobox (HHEX)
which is required for hematopoietic cell differentiation, and
elongation factor 1 alpha 1 (EF1A1), which is a component of
transcription factor complex of T helper 1 cells (Maruyama
et al., 2007; Lukas et al., 2009; Goodings et al., 2015). In
addition to PCGF5, TRP120-interacting transcription factors
include interleukin enhancer binding factor 3 (ILF3), a subunit
of the nuclear factor of activated T-cells (NFAT), which is
a transcription factor required for T-cell protein expression
(Nakadai et al., 2015); lysine (K)-specific demethylase 6B
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FIGURE 2 | Illustration of TRP effector domains. (A) TRPs are a post-translationally modified effectors. Many modifications have been detected in the tandem
repeat domains which also have been shown to contain the DNA-binding domain. SUMOylation sites (SUMO) are identified by pink rectangles. (B) E. chaffeensis
effectors subvert host cellular functions. (1) Ehrlichial effectors hijack host post-translational machinery and acquire post-translational modifications that regulate
effector function and interactions. TRP47 interacts with the tyrosine kinase FYN1 and is phosphorylated. TRP120 is SUMOylated by SUMO ligase UBC9 and may
involve other undefined SUMO E3 ligase. This PTM is required for multiple interactions with SUMO-binding domain containing host proteins such as PCGF-5 and
GGA1. Ehrlichia effectors also interact with host PTM machinery to manipulate host pathways. TRP120 interacts with Kelch-like 12 (KLHL12) an E3 ligase in the BCR
(BTB-CUL3-RBX1) complex which ubiquitinates disheveled 3 (DVL3) in order to negatively regulate Wnt signaling. TRP120 interaction with KLHL12 may prevent this.
(2) Ehrlichial effectors also regulate host gene expression. SUMOylated TRP120 interacts with PCGF5 and resulting in recruitment out of the nucleus. Ank200 and
TRP120 directly interact with host chromatin leading to the differential expression of host genes. TRP32 interacts with several host transcription factors and may also
influence host gene expression.
(KDM6B) and transducin-like enhancer protein 4 (TLE4), both
involved in regulation of transcription from RNA polymerase
II promoter (Milili et al., 2002; Ohtani et al., 2013); nuclear
receptor binding SET domain protein 1 (NSD1), which is a
basic transcriptional factor and bifunctional transcriptional
regulator (Lucio-Eterovic et al., 2010); and tripartite motif
containing 24 (TRIM24), which mediates transcriptional
control by interacting with the activation function 2
region of several nuclear receptors (Thenot et al., 1997).
Therefore, irrespective of their role as direct transcriptional
regulators, TRPs may regulate host gene transcription via
their interactions with other host transcription factors and
cofactors.
Notably, TRP Y2H studies have also discovered likely
interactions with several apoptosis-associated proteins of the host
cell (Luo et al., 2011). Several common interacting proteins of
the TRPs, including EF1A1, RPL11 and various immunoglobulin
light chains, which have been linked to apoptosis regulation.
In addition, TRP32 interacts with tumor protein p53 inducible
protein 11 (TP53I11), which is a downstream target of p53
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and is also involved in the regulation of apoptosis (Wu et al.,
2009). TRP47 interacts with adenylate cyclase-associated protein
1 (CAP1), which has been implicated in promoting apoptosis
by functioning as an actin shuttle to mitochondria (Wang
et al., 2008). TRP120 interacts with intercellular adhesion
molecule 3 (ICAM3) (Luo et al., 2011), which can activate
the Akt/ERK/CREB2 pathway and block apoptosis, and protein
phosphatase 3 regulatory subunit B alpha (PPP3R1), which
positively regulates protein insertion into the mitochondrial
membrane and the apoptotic signaling pathway (Su et al., 2012;
Ahn et al., 2013). Thus, the interactions of the TRPs with different
host proteins associated with apoptosis may serve to inhibit or
to promote apoptosis at different stages of infection to facilitate
ehrlichial survival and release, respectively.
Interestingly, E. chaffeensis TRPs also interact with numerous
host proteins associated with cellular signaling pathways,
particularly Wnt pathways (Table 1). TRP32-interacting protein
DAZAP2 is a highly conserved protein that modulates gene
transcription driven by theWnt/β-catenin signaling effector TCF
(Lukas et al., 2009). TRP47-interacting protein CYP4F3 is a
member of the cytochrome P450 superfamily of monooxygenases
and is a target of Wnt/β-catenin pathway (Corcos et al., 2012).
Many TRP120-interacting host proteins are involved in both
canonical and noncanonical Wnt signaling pathways and Wnt
ligand secretion. E. chaffeensis has recently been demonstrated
to exploit Wnt pathways through TRP-Wnt signaling protein
interactions (Luo et al., 2015). In addition, TRP120 interacts
with ADAM17 metalloprotease, indicating that Notch signaling
pathway may also be involved in the ehrlichial infection (Luo
et al., 2011).
POST TRANSLATIONAL MODIFICATIONS
Protein post-translational modifications (PTMs), such as
phosphorylation, acetylation, ubiquitination and SUMOylation
regulate many cellular processes. PTMs are rapid, reversible,
controlled and highly specific, and provide a tool to regulate
protein stability, activity, and localization. Numerous examples
exist where pathogens target, manipulate and exploit host PTMs
to facilitate a survival strategy (Ribet and Cossart, 2010a).
It is established that bacterial pathogens exploit host PTM
machinery to promote bacterial survival and replication. Many
bacterial effectors mimic host proteins involved in the host post-
translational machinery to modify host proteins and signaling
(Ribet and Cossart, 2010b).
Phosphorylation
Protein phosphorylation plays a role in several key steps of
the infectious process of bacterial pathogens such as adhesion
to the host, triggering, and regulating pathogenic functions,
altering host signaling cascades and impairing host defense
mechanisms. The bacterial outer membrane is the primary
contact between Ehrlichia and the host cell. The surface-
exposed proteins in E. chaffeensis include the outer membrane
protein family (OMP-1) (Ohashi et al., 2001) and secreted
effectors TRP47 and TRP120 (Doyle et al., 2006; Luo et al.,
2009, 2010; Wakeel et al., 2010). The differentially expressed
OMPs are post-translationally modified by phosphorylation and
glycosylation to generate multiple expressed forms (Singu et al.,
2005). However, it is not clear how these PTMs affect protein
function or interactions with the host cell. The TRPs exhibit
high serine/threonine content and contain predicted sites for
phosphorylation. TRP47 interacts with the Src family tyrosine
kinase, Fyn, a key component of the αβTCR-coupled signaling
pathway, which may be involved in the tyrosine phosphorylation
of TRP47 (Wakeel et al., 2010). TRP75 and Ank200 are
also tyrosine phosphorylated, although the specific modified
residues remain undefined (McBride et al., 2011). It is not
clear which protein kinases phosphorylate Ank200 or how this
phosphorylation is regulated, but AnkA of A. phagocytophilum is
tyrosine phosphorylated by the Abl-1 tyrosine kinase. However,
there are some functional similarities between Ank200 and AnkA
associated with host gene transcription (Garcia-Garcia et al.,
2009; Zhu et al., 2009).
SUMOylation
SUMOylation, the covalent attachment of a member of the
small ubiquitin-like modifier (SUMO) family of proteins to
lysine residues in targeted proteins, is an essential post-
translational protein modification for all eukaryotic cells. A
number of bacterial pathogens are known to directly target the
SUMOylation system in order to modulate overall SUMOylation
levels in the host cell (Ribet and Cossart, 2010c). However,
intracellular bacteria that exploit host cell SUMOylation to
modify pathogen proteins as part of their intracellular survival
strategy has been limited to Ehrlichia and Anaplasma (Dunphy
et al., 2014; Beyer et al., 2015). Recently, the E. chaffeensis
T1S effector TRP120 was found to be modified by SUMO
at a canonical consensus SUMO conjugation motif located in
the C-terminal domain in vitro. SUMOylation site was further
confirmed using a high-density microfluidic peptide array (Zhu
et al., 2016). In human cells, TRP120 conjugation with SUMO2/3
isoforms mediates interactions with host protein targets such
as polycomb repressive proteins, actin and myosin cytoskeleton
components or GGA1, which is involved in vesicular trafficking.
Inhibition of the host SUMO pathway with a small-molecule
inhibitor significantly decreases interaction between TRP120
and PCGF5, as well as decreasing PCGF5 recruitment to the
ehrlichial vacuole. More importantly, inhibition of this pathway
also decreases ehrlichial intracellular survival (Dunphy et al.,
2014).
Ubiquitination
Another highly dynamic PTM that is implicated in signaling
pathways is ubiquitination. Ub (ubiquitin) is a small, 76-amino
acid protein which is highly conserved and widely expressed
in all eukaryotic cells. Ubiquitination involves one or more
covalent additions of Ub to the lysine residues of target proteins
(i.e., mono- or poly-ubiquitination). Ubiquitin-dependent post-
translational modification systems have important roles in
several aspects of bacterial pathogenesis as well as in host
defense responses. TRP120 was previously reported to interact
with components of the Ub PTM pathways, including the E3
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TABLE 1 | E. chaffeensis TRPs interact with host Wnt pathway associated components.
TRP Host protein Property/Function in Wnt signaling
TRP32 DAZAP2 Modulates gene transcription driven by Wnt/β-catenin signaling effector TCF
TRP47 CYP4F3 A target of Wnt/β-catenin pathway
TRP120 ARID1B Interacts with β-catenin to suppress Wnt signaling
CEP164 Interacts with DVL3
KDM6B β-catenin binding; activates Wnt3 or DKK1 to stimulate or suppress Wnt signaling at different stages
KLHL12 Interacts with DVL3 for degradation
ILF3 A subunit of transcription factor NFAT
LMO2 Interacts with Axin1 and DAZAP2
IRF2BP2 Interacts with NFATC2 to repress transcriptional activity
PPP3R1 Calcineurin regulatory subunit 1; calcium ion and calmodulin binding; calcium-dependent protein phosphatase activity; NFAT import into
nucleus
TLE4 Represses gene transcription by TCF
VPS29 Retrograde transport of proteins from endosomes to the trans-Golgi network; Wnt ligand biogenesis, secretion, trafficking
ligases, KLHL12, and FBW7 (F-box and WD repeat domain-
containing 7, part of SCF, which is a E3 ligase complex), as
well as Ub isoforms UBB and UBC, which suggests TRP120
is a target of Ub conjugation (Luo et al., 2011). However,
it remains unclear whether the functional consequences of
TRP120 ubiquitination are different from those associated with
SUMOylation of TRP120. Thus, further study is needed to
understand how Ub PTMs influence TRP120 function.
CYTOSKELETAL ORGANIZATION AND
VESICLE TRAFFICKING
Decreased expression of genes such as SNAP23 (synaptosomal-
associated protein, 23 kDa), Rab5A (member of RAS oncogene
family), and STX16 (syntaxin 16), which are involved in
membrane trafficking are observed during E. chaffeensis
infection. TRP120 and Ank200 bind genes involved in vesicle
trafficking and cytoskeletal rearrangement such as clathrin
(CTLA), syntaxins (SNX14, SNX11, SNX17), coatomer (COPA),
and TSNARE1. At the protein level, TRP120 interacts with host
proteins actin gamma 1 (ACTG1), actin related protein 2/3
complex (ARPC2), and unc-13 homolog D (UNC13D) (Luo
et al., 2011). Since, inhibition of actin polymerization in E.
chaffeensis infected cells prevents filopodia formation (Thomas
et al., 2010), it is likely that the interaction of TRP120 with actins
might play important role in ehrlichial entry and release from
host cell. TRP47 interacts with CAP1 (actin binding protein
adenylate cyclase protein 1) at the morula membrane interface
and changes the distribution of CAP1 during infection. This
multifunctional protein binds with actin, cofilin, SH3 domain,
profilin, and adenylyl cyclase and is involved in receptor-
mediated endocytosis and vesicle trafficking (Wakeel et al.,
2009). It is possible that Ehrlichia mediated regulation of genes
and protein expression associated with cytoskeletal components
might facilitate vesicular trafficking, entry, and exocytosis during
infection.
EXPLOITING CONSERVED CELL
SIGNALING PATHWAYS
E. chaffeensis manipulates host cellular processes to create
a favorable environment by reprogramming cell-signaling
pathways and inhibiting bactericidal activity, most likely through
specific interactions of its surface-expressed and/or secreted
effector proteins. Intracellular survival and proliferation of
E. chaffeensis involves activation of conserved cell signaling
pathways (e.g., Wnt), suppression of tyrosine and mitogen-
activated protein kinase (MAPK) activity and downregulation
of Toll-like receptors and transcription factors, in monocytes
and macrophages. Different gene targets of Ank200 and TRP120
are transcription factors in various host cell signaling pathways.
Additionally, several host cell signaling proteins are regulated by
TRPs and Ank200 at gene and protein levels (Zhu et al., 2009,
2011).
Wnt Signaling
Previously, Wnt pathway components and regulators were found
to interact with ehrlichial TRP effectors (Table 1) (Luo et al.,
2011). Some of these interactions need further confirmation in
mammalian cells; however, exploitation of the Wnt pathway
by E. chaffeensis has been conclusively established. Most
recently, it was demonstrated that host Wnt signaling plays an
important role in ehrlichial internalization and infection, and
that ehrlichial TRPs mediate bacterial invasion and survival
through activation and modulation of Wnt signaling pathways
(Luo et al., 2015). Canonical and noncanonical Wnt signaling
is significantly stimulated during early stages of infection (1–
3 h), as expression of Wnt signaling genes are altered, which
coincides with dephosphorylation and nuclear translocation of
β-catenin and NFATC1. Knockdown of major Wnt signaling
molecules such as Wnt5a, Fzd5, β-catenin and NFAT, or
TRP-interacting Wnt pathway components/regulators such as
ARID1B, KDM6B, IRF2BP2, PPP3R1, and VPS29, results in
significant reductions in ehrlichial load. Wnt5a-Fzd5 signaling
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FIGURE 3 | E. chaffeensis mediated activation of Wnt signaling pathway and function. TRP proteins interacts with unknown Wnt receptors and activating
both canonical and noncanonical Wnt signaling through activation of Dvl. (1) Activation of the Wnt/PCP pathway and the Wnt/ Ca2+ pathway causes translocation of
transcription factor NFAT to the nucleus and results in target gene expression. TRP induced activation of noncanonical Wnt pathway activation triggers phagocytosis
and helps in bacterial internalization. After internalization, E. chaffeensis induces expression of the receptor Fzd5 and possibly the ligand Wnt5a. Interaction of Wnt5a
with Wnt receptor Fzd5 causes increased Ca2+ release and NFAT translocation to nucleus. This signaling plays a major role in ehrlichial survival. (2) Both ehrlichial
TRPs and Wnt5a can interact with the unknown receptor and LRP6 co-receptor and activate canonical Wnt signaling pathway. Activation of canonical Wnt signaling
results in dephosphorylation and translocation of β-catenin into the nucleus within 1 h p.i. Unphosphorylated β-catenin associates with TCF/LEF family of transcription
factors and causes induction of Wnt target genes. Activation of these genes are essential for ehrlichial survival. TRPs interact with important components and
regulators of Wnt pathway (shown in purple) and thus regulate Wnt signaling.
appears to be very important for Ehrlichia survival after
internalization, consistent with previous report that Wnt5a-Fzd5
signaling reduced bacterial killing by macrophages (Maiti et al.,
2012). Moreover, small molecule inhibitors specific for canonical
and noncanonical Wnt pathways components and Wnt ligand
secretion significantly decrease ehrlichial load (Figure 3; Luo
et al., 2015).
TRPs directly activate Wnt signaling and trigger phagocytosis
(Luo et al., 2015). TRP-induced phagocytosis appears to be
primarily a noncanonical mode of Wnt signaling most likely
through Rac1-PI3K-IKK of Wnt/PCP signaling, similar to
Wnt5a-induced phagocytosis; however it appears that Ehrlichia
internalization is dependent on TRP/receptor interaction and
independent of Wnt ligand secretion. Further investigation
is needed to identify the TRP-interacting receptor and
understand the importance of specific Wnt pathways in
ehrlichial pathobiology.
Notch Signaling Pathway
The Notch signaling is an evolutionarily conserved pathway
in eukaryotes. It plays important roles in cell proliferation
and differentiation, and thereby influencing cell fate
(Artavanis-Tsakonas et al., 1999; Hoyne, 2003; Fortini, 2012;
Radtke et al., 2013). Recently this pathway has been recognized
as an important regulator of the innate and adaptive immune
responses including inflammation, autophagy (Barth and
Kohler, 2014), apoptosis (Palaga, 2003), Toll-like receptor (TLR)
expression (Zhang et al., 2012), T and B cell development
(Hoyne, 2003), and MHC class II expression (Ganta et al., 2002)
in different immune cells. Cleavage of the Notch receptor by
furin, ADAM metalloprotease and γ-secretase, releases the
transcriptionally active intracellular domain (NICD), which
translocates to the nucleus and forms a tri-protein complex
with RBPjκ (CSL) and MAM to activate Notch target gene
transcription (Barrick and Kopan, 2006; Kovall, 2007). Recently,
TRP120 interaction with host genes associated with the Notch
signaling pathway, e.g., notch1, was reported (Zhu et al.,
2011). TRP120 interacts with ADAM17 metalloprotease, a
critical enzyme involved in Notch signaling pathway, and with
important regulators of Notch signaling such as NEDD4L and
FBW7 (Luo et al., 2011). Both proteins act as negative regulators
of Notch signaling (Figure 4). NEDD4 E3 ligase ubiquitinates
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FIGURE 4 | Survival strategies used by E. chaffeensis during intracellular development. (1) TRP120 interacts with some important enzymes involved in the
activation and regulation of host Notch signaling pathways e.g., ADAM17, NEDD4L, and FBW7. These TRP-protein interactions might play an important role in
modulation and exploitation of the Notch pathway. (2) E. chaffeensis causes decreased PRR (TLR 2 and 4) expression through downregulation of ERK1/2 and p38
MAPK cell signaling molecules and subsequent inhibition of PU.1 transcription factor. (3) Interaction of TRP47 with host protein PTPN2 or induction of host cell protein
kinase A (PKA) by Ehrlichia causes inhibition of IFN-γ mediated tyrosine phosphorylation of JAk/STAT and thus causes decreased cytokine production. (4)
E. chaffeensis uses a two component system (TCS) for the inhibition of phagosome lysosome fusion and thus protect itself from degradation by autophagy. (5) The
effector protein ECH0825 protects Ehrlichia from ROS by induction of MnSOD and inhibits Bax mediated apoptosis. (6) TRPs interact with host cytoskeletal proteins
to facilitate exocytosis or filopodium formation, which helps direct cell to cell transfer. TRP interacting proteins are shown in purple.
Notch and regulates Notch cell surface expression by triggering
its removal from the cell surface and targeting it for lysosomal
degradation (Wilkin et al., 2004). Both the Notch receptor and
the γ-secretase proteolytic protein component presenilin are
substrates of FBW7 (Wu et al., 1998; Li et al., 2002). Modulation
of Notch pathways by intracellular bacteria such as Salmonella
typhimurium, Mycobacterium bovis and Bacillus anthracis has
been reported where the bacteria altered the Notch pathway
to regulate inflammation in the host cell (Narayana and Balaji,
2008; Larabee and Ballard, 2014). Crosstalk between Wnt and
Notch signaling pathways has also been widely studied (Collu
et al., 2014). The interaction of TRP effectors with critical
Notch signaling components suggests that the Wnt pathway is
undoubtedly not the only conserved pathway that is modulated
or exploited by Ehrlichia. Further studies are needed to fully
characterize the Notch pathway during infection and determine
how the Wnt and Notch pathways are exploited to promote
ehrlichial survival.
MODULATION OF INNATE IMMUNE
RESPONSE
E. chaffeensis preferentially infects mononuclear phagocytes and
has evolved remarkable strategies to survive and replicate within
these primary immune cells. During infection, the immune
recognition receptors and the cytokine responses which serve
as the primary host defense mechanism are downregulated.
Ehrlichia induces phagocytosis to enter the host cell, but inhibits
the fusion of the Ehrlichia vacuole with lysosomes. It also
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manipulates several other host responses such as apoptosis, ROS
production and IFN-γ responsiveness (Figure 4).
Differential Expression of Pattern
Recognition Receptors (PRRs)
Innate immune cells such as monocytes and macrophages
express many pattern recognition receptors (PRRs) that are
activated upon recognition of pathogen-associated molecular
patterns (PAMPS). Different PRRs expressed on the cell surface
or endosomal membrane recognize different PAMPS and
activate NFκB, ERK1/2, p38 MAPK, and JNK pathways, causing
increased proinflammatory cytokine and chemokine production.
This response plays a critical role in pathogen elimination (Guha
and Mackman, 2001; An et al., 2002). TLR2 and TLR4 are the
most well characterized PRRs that detect lipoproteins and LPS,
respectively (Takeuchi et al., 1999). Though E. chaffeensis lacks
the genes required for biosynthesis of LPS and PG, this unique
cell wall structure does not prevent detection by immune cells.
Studies have shown that inhibition of TLR4 causes decreased
levels of nitric oxide and IL-6 secretion by macrophages
and results in short term persistence of E. chaffeensis (Ganta
et al., 2002). Moreover, in vivo studies demonstrated that
TLR2/4-dependent immune responses play a protective role in
E. chaffeensis clearance (Chattoraj et al., 2013). However, TLR2/4
and CD14 expression and the related cytokine production
are downregulated during ehrlichial infection. The underlying
mechanism involves inhibition of ERK1/2, p38 MAPK that
regulates expression of PU.1, a transcription factor required
for TLR2 and 4 expression (Lin and Rikihisa, 2004). The
intracellular PRRs, such as nucleotide-binding oligomerization
domain (Nod)-like receptor proteins Nod1 and Nod2, are
also differentially expressed during E. chaffeensis infection.
Nod1 and Nod2 signals through Rip2 adaptor molecule,
activating NFκB and MAPK, which results in production of
immunoregulatory molecules such as chemokines and cytokines
(Ogura et al., 2001; Kersse et al., 2011). Induction of the
NLRs negatively regulates anti-ehrlichial protective immunity
and causes increased inflammatory immune response, and thus
enhances host susceptibility to Ehrlichia induced toxic shock
(Chattoraj et al., 2013).
Differential Expression of Cytokine and
Chemokines
Since E. chaffeensis does not express well-known PAMPs such
as LPS, PG, pili, and flagella or capsule (Lin and Rikihisa,
2003a; Mavromatis et al., 2006), the PAMP-triggered cytokine
and chemokine production appears to depend in part on the
bacteria mediated modulation of host cell signaling molecules.
Both MyD88 dependent and TLR dependent/independent
cytokine response have been shown during ehrlichial infection.
Differences between PRR signaling and cytokine production also
exists between different Ehrlichia strains. E. chaffeensis Wakulla
strain causes inflammatory cytokine production throughMyD88,
ERK, and NFκB, but not through TRIF, IL-1R1, or any TLR
(Miura et al., 2011). E. chaffeensis Arkansas strain on the other
hand inhibits protective cytokine production through inhibition
of TLR2, TLR4, and CD14. The infected cells progressively
become resistant to LPS stimulation and show decreased
activation of ERK1/2, p38 MAPK and NFκB (Lin and Rikihisa,
2004). Microarray studies have also demonstrated inhibition of
IL-12 and IL-18 expression during infection, which are important
inducers of a Th1 mediated immune response (Zhang et al.,
2004). Thus far, the only known protein that causes induction
of MyD88 dependent inflammation is a low-molecular-weight
penicillin-binding protein (Rahman et al., 2012). TRPs have
shown to be associated with the regulation of different cytokine
and chemokine gene expression. TRP120 acts as a nucleomodulin
and causes induction of TNF-α, CCL20, CXCL11, and CCL2 gene
expression, which suggests its role as transcriptional regulator
of these cytokine and chemokines (Zhu et al., 2011). Ank200
binds to the promoter region of TNF-α and may induce TNF-α
production (Zhu et al., 2009).
Inhibition of Autophagy
In eukaryotes, cellular degradation of cytoplasmic components
is vital, since this cellular pathway removes toxic components
and misfolded protein aggregates and protects them from
invading pathogens and also provides nutrients through
recycled degradation products. This intracellular degradation
process known as autophagy is mediated by a unique double
membrane organelle called an autophagosome, which engulfs
and transports cytoplasmic components to the lysosome for
degradation. It also serves as an innate immune response
pathway that targets intracellular bacteria in the cytoplasm
or in the phagosome for degradation (Klionsky et al., 2007;
Shahnazari and Brumell, 2011). Though autophagy is normally
induced during a bacterial infection, Ehrlichia appears to inhibit
autophagy during infection. This is a very important immune
evasion mechanism for ehrlichial survival since they reside
in professional phagocytes, which are abundant in lysosomes.
Recent studies have reported that ehrlichial vacuoles do not
contain autophagy markers, and are not acidic (Cheng et al.,
2014). Instead, E. chaffeensis resides in late endosome that
fail to fuse with lysosomes (Cheng et al., 2014). Although
no detailed studies have been conducted to understand how
Ehrlichia inhibits autophagy, a role for the functional two
component system in inhibition of phagosome lysosome fusion
during ehrlichial infection has been reported. Treating the cells
with the histidine kinase inhibitor closantel (two component
inhibitor) prior to infection has been shown to increase co-
localization between E. chaffeensis and lysosomal glycoprotein
LAMP-1 (Cheng et al., 2006). Though autophagy can be
induced or activated by several signal transduction events, the
central regulator of autophagy is mTOR. During starvation
conditions mTOR phosphorylates ULK1 and Atg13 and thus
inhibits the initial ULK1 complex formation, which is the
first step of the autophagophore formation. Both Notch and
Wnt signaling play a crucial role in inhibition of autophagy
through regulating the activation of the mTOR pathway
and inhibiting the expression of the autophagy receptor
p62 (Lapierre et al., 2011; Bailis and Pear, 2012; Petherick
et al., 2013; Fu et al., 2014). It is likely that E. chaffeensis
inhibits the fusion of this compartment with lysosomes
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by manipulating host cell signaling pathways to facilitate
proliferation and survival. Although, activation of the Wnt
and possibly Notch pathways occurs during ehrlichial infection
and is required for survival, the role of these pathways in
inhibition of autophagy has not been examined. Understanding
the role of the Wnt and Notch pathways in induction of
autophagophore formation and subsequent inhibition of its
fusion with the lysosome during ehrlichial infection is currently
under investigation.
Inhibition of Monocytes/Macrophage
Activation Signals
IFN-γ produced by T cells serves as one of the key regulators
of both the innate and adaptive immune responses against
intracellular pathogens. This macrophage-activating cytokine
induces antigen presentation, phagocytosis, cytokine production,
and regulates iron homeostasis, which is required for production
of antimicrobial effectors including reactive oxygen species
(ROS) and nitric oxides (NO) (Farrar and Schreiber, 1993;
Collins, 2003, 2008). IFN-γ inhibits E. chaffeensis infection at
early stages by inhibiting iron availability which is important
for the survival of intracellular bacteria such as Salmonella,
Listeria, Mycobacteria and Ehrlichia (Collins, 2003; Schaible
and Kaufmann, 2004). However, IFN-γ shows no anti-ehrlichial
effect when infection is established. The mechanisms involve
induction of transferrin receptor expression on the surface
and disruption of Janus kinase (Jak) and signal transducer
and activator of transcription (Stat) signaling induced by
IFN-γ. E. chaffeensis blocks tyrosine phosphorylation of Stat1,
Jak1, and Jak2 in response to IFN-γ through raising PKA
activity in THP-1 cells soon after infection (Lee and Rikihisa,
1998). TRP47 might play an important role in the inhibition
of IFN-γ-induced tyrosine phosphorylation of Stat1, Jak1,
and Jak2 by interacting with PTPN2 (Wakeel et al., 2009).
PTPN2 also known as T cell PTP (TC-PTP), regulates
phosphotyrosine levels in signal transduction pathways and
targets several important host cell signaling receptors and
components including CSF-1R, EGFR, PDGFR, IR, p52Shc,
Stat1, Stat3, Stat5a/b, Stat6, Jak1, and Jak3. Both in vivo and
in vitro data indicate that PTPN2 can also regulate cytokine
signaling by regulating Jak/Stat pathway. Inhibition of PTPN2
causes Stat5 activation, increased production of IFN-γ, TNF-
α, IL-12, and inducible nitric oxide synthase (iNOS). PTPN2
inhibition also results in increased tyrosine phosphorylation,
enhanced activation of ERK, and may affect transcription
factor PU.1 signaling (Stuible et al., 2008; Doody et al., 2009).
TRP120 and Ank200 target genes of important components
of the Jak-Stat pathway, e.g., Jak2, Stat1, Stat3, Stat5, and
IFNR2, and thus might be involved in regulation of IFN-
γ signaling during infection (Zhu et al., 2009; Luo et al.,
2011).
Downregulation of Reactive Oxygen
Species (ROS)
Reactive oxygen species produced by nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase is one of the major
antimicrobial defense mechanisms used by the host. NADPH is
a multicomponent enzyme which is composed of cytochrome
b558 component (gp91
phox, p22phox), three cytosolic subunits
p67phox, p47phox, and p40phox and a low molecular weight
GTPase (Rac1/2 or Rap1A) (Babior, 1999; Fang, 2004). Upon
invasion of pathogens, these components assemble to form a
holoenzyme that produces a superoxide anion (O−2 ) from the
oxygen that serves as the starting material for production of
different ROS such as hydrogen peroxide (H2O2), hydroxyl
radicals, singlet oxygen, and oxidized halogens. E. chaffeensis
lacks the genes required for ROS detoxification such as
copper zinc superoxide dismutase (CuZnSOD), manganese
superoxide dismutase (MnSOD), peroxidase, glutathione
peroxidase/reductase, catalase, and OxyR/SoxRS regulons. These
enzymes are utilized by many facultative intracellular bacteria.
Because of the absence of these enzymes Ehrlichia is rendered
uninfectious when exposed to H2O2 or O
−
2 (Barnewall et al.,
1997). Interestingly, ehrlichiae can successfully replicate in
monocytes and macrophages which are the primary producers of
ROS by actively inhibiting or blocking O−2 generation. Ehrlichia
mediated inhibition of superoxide generation is cell specific
since it can inhibit the ROS production only in macrophages,
but not in neutrophils (Lin and Rikihisa, 2007). The underlying
mechanism involves degradation of the p22phox unit of
NADPH. This degradation does not require ubiquitination
and occurs independently of intracellular signaling, but shows
the involvement of iron and the interaction between Ehrlichia
and host cell membrane proteins (Lin and Rikihisa, 2007).
One of the E. chaffeensis two component systems CckA-CtrA
regulates ehrlichial gene expression during late infection and
plays a role in protecting ehrlichiae from ROS (Cheng et al.,
2006).
Inhibition of Host Cell Apoptosis
In multicellular organisms, the number of cells is tightly
regulated by cell division and programmed cell death, also
known as apoptosis. It is an intrinsic immune mechanism
which prevents proliferation of intracellular bacteria (Sly
et al., 2003). In response to bacterial infection apoptosis is
induced as an innate host immune response. It eliminates
the pathogen in the early stages of infection, induces antigen
presenting cells to engulf apoptotic bodies and allows antigens
to be recognized by MHC molecules and thus induces a
protective immune response (Elliott and Ravichandran, 2010).
Spontaneous neutrophil apoptosis is delayed by stabilization
of the mitochondrial membrane potential during E. ewingii
infection (Xiong et al., 2008). E. chaffeensis also appears to
suppress apoptosis to promote cell survival. Despite inhibition
of multiple mitochondrial activities during E. chaffeensis
infection, mitochondrial membrane potential is maintained
and apoptosis inhibited (Liu et al., 2011). Cell cyclins and
cyclin dependent kinase (CDK) expression are differentially
regulated during infection. Apoptotic inhibitors e.g., IER3,
BirC3, BCL2, and BCL related proteins such as MCL1 and
BCL2A1 are induced during the infection (Zhang et al., 2004).
On the other hand, apoptotic inducers such as hematopoietic
cell kinase (HCK), BIK, and BNIP3L are downregulated during
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early infection (Zhang et al., 2004). The T4SS effector ECH0825,
which is highly upregulated during exponential growth in
human monocytes, localizes to mitochondria and inhibits
Bax induced apoptosis. This protein also causes induction of
mitochondrial manganese SOD (MnSOD) and decreases ROS
level. The upregulation of MnSOD prevents ROS-mediated
cellular damage and apoptosis (Liu et al., 2012). Y2H data
demonstrates TRP-host protein-protein interactions may also
modulate programmed cell death responses. Interaction of TRPs
with apoptosis-associated proteins and their potential role as
regulators of apoptosis have been discussed in detail in previous
section (Section TRP-Host Protein Interactions). Further
studies are needed to understand the cellular and molecular
mechanisms involved in apoptosis regulation during ehrlichial
infection.
TARGETING HOST EPIGENETIC
MACHINERY
By altering host transcription and protein profile, E. chaffeensis
promotes its survival and creates a replicative niche inside the
host (Luo et al., 2011; Luo and McBride, 2012). These changes
modulate a wide range of host cellular pathways that E. chaffeensis
exploits for its own survival. Recent studies suggest that these
changes in the host transcriptome and proteome are not only
due to activation of different cell signaling pathways, but also
due to direct interaction of pathogen-derived proteins with host
chromatin and/or chromatin modifying proteins.
E. chaffeensis effector proteins such as Ank200 and TRP120
target genes involved in post-translational modification of
histones, which includes histone deacetylase 1, 2, and 8 (HDAC1,
2, and 8) and SET domain containing protein which functions
as DNA methyltransferase (DNMT). E. chaffeensis TRP120
also interacts strongly with chromatin-associated proteins,
which include the histone methylase (NSD1), demethylases
(KDM6B/JMJD3), protein components of the SWI/SNF
chromatin remodeling complex (ARID1B), and PCGF5, a
paralogous member of the polycomb group (PcG) proteins (Di
Croce and Helin, 2013). PcG proteins fall into two functionally
distinct protein complexes, Polycomb repressive complex
(PRC) 1 and 2, and are involved in transcriptional repression
of eukaryotic genes via post-translational modification of
histones. The core components of the PRC1 complex include
one subunit of a PCGF paralog (PCGF1, PCGF2/Mel-18,
PCGF3, PCGF4/Bmi-1, PCGF5, and PCGF6), one subunit of a
CBX (chromobox homolog) paralog and PHC (Polyhomeotic)
paralog, and RING1 (really interesting new gene) paralogs
(RING1/RING1b). RING1 is a functional E3 ubiquitin ligase,
responsible for catalyzing ubiquitination of H2A at lysine 119
(H2AK119ub), while EZH (Enhancer of zest) homologs in
PRC2 complex exhibits histone methyltransferase activity and
produces tri-methylation of H3 at lysine 27 (H3K27me3) (Morey
and Helin, 2010). The composition of the PRC1 complex is
dynamic and the interaction of a particular PCGF isoform to
its cognate RING protein results in recruitment of the other
component of the repressive complex to its target site (Gao
et al., 2012). Though there is an ambiguity in the process of
PRC1 recruitment to its target location, the prevailing opinion
is that it proceeds in a hierarchical fashion and requires prior
nucleation of PRC2 and placement of H3K27me3 at the target
location.
Polycomb group proteins were first identified in fruit flies
(Drosophila melanogaster) as transcriptional repressors of
Hox genes (Lewis, 1978). Hox genes encode Homeodomain
containing transcription factors, involved in cellular
differentiation and proliferation, and govern the anterior-
posterior body patterning during embryo development
(Sauvageau and Sauvageau, 2010). Since ehrlichial TRP proteins
interact with host PCGF5 and most like to other polycomb
group proteins (Wakeel et al., 2009; Luo et al., 2011), we are
currently investigating the mechanism by which E. chaffeensis
epigenetically regulates Hox gene expression to prolong its
survival inside the host cell.
CONCLUSION
Ehrlichiosis is difficult to diagnose, and delayed treatment
can lead to serious complications and even death. Currently,
there are no vaccines available for HME, and therapeutic
options are limited. Rapid growth in antibiotic resistance
among microbes and the lack of broader therapeutic options
is concerning. Recent advances in our understanding of
the pathogenesis of ehrlichial infection, molecular pathogen-
host interactions, characterization of newly discovered TRPs
and Anks and defining their role in exploiting host PTM,
conserved cell signaling pathways and modulation of epigenetic
machinery have provided new targets for therapeutics. Moreover,
the TRPs contain species-specific epitopes that are highly
immunogenic and protective, which suggests they can be
used as vaccine candidates, and that the passive transfer of
antibodies can serve as a therapeutic. Considerable advances
have been made in understanding the cellular and molecular
mechanisms used by the organism in reprogramming conserved
cell signaling pathways to modulate cellular processes that
enables ehrlichiae to survive inside phagocytic cells. Moreover,
recent understanding of the role of these effector molecules
in exploiting host PTMs and modulating host epigenetic
machinery suggest their moonlighting functions in manipulating
multiple host cellular processes. E. chaffeensis represents a model
system to investigate complex pathogen-host interaction and to
explore the specific cellular pathways exploited by intracellular
pathogens for survival and persistence. Thus, further studies
regarding the effector mechanisms and host processes that are
affected by these modulations will be beneficial for designing
new therapeutics for Ehrlichia, as well as other intracellular
bacteria.
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